Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, findings confirmed by data from a series of new imaging techniques and ...

In a clinical abstract session on imaging aspects of ... OP0222 Sacroiliac bone marrow oedema on postpartum MRI does not ...